Skip to main content
. 2000 Dec 12;97(26):14317–14322. doi: 10.1073/pnas.250488697

Table 1.

Characterization of MEL cell transfectants

Clone Doxycycline T(g)* G1, % B+, % C, %§
p15.25 12.2 31.6 2 1
+ 12.4 31.7 1 2
p15.47 11.8 31.7 2 2
+ 11.9 32.4 2 2
p16.8 11.9 33.4 1 2
+ 24.3 50.6 3 2
p16.11 11.9 30.7 2 3
+ 25.3 52.3 1 3
p21.12 11.8 29.6 2 2
+ 55.5 33.3 34 36
p21.35 11.9 30.7 1 3
+ 52.3 33.4 31 33
p27.16 12.1 28.3 2 2
+ 42.1 84.9 1 3
p27.77 11.9 27.6 1 3
+ 40.2 87.8 1 1
MELrtTA 11.9 29.1 1 2
+ 11.7 28.5 2 3
*

Doubling time [T(g)] was determined by counting cell numbers with a Coulter counter at intervals of 24 h in samples of the indicated transfectants incubated in the presence (+) or absence (−) of doxycycline for 14 days at 37°C. 

Percentage of cells in (G1, %) was determined by fluorescence-activated cell sorter scan analysis as described in Materials and Methods on aliquots of cells incubated the presence (+) or absence (−) of doxycycline for 36 h at 37°C. 

Percentage of benzidine-positive (B+) cells was determined as described in Materials and Methods on aliquots of cells incubated for 5 days. 

§

Percentage of cells committed to terminal differentiation (C, %) was determined by plasma clot assays as described in Materials and Methods on aliquots of cells incubated for 4 days.